Subjects with diseases potentially linked to diet and dietary modifications were excluded from the control group, and major confounding factors of prostate cancer were adjusted for.
Any patients meeting any exclusion criteria, those on vasoactive drugs, such as prostanoids, or patients undergoing frequent treatment modifications, were excluded.
Peptide fragments in the 0.05% hydrogen peroxide monomer containing no modifications were excluded from analysis because they contain no information about the percent exposure of residues in the fibril.
However, possible sources of selection bias are limited in our study, as cases and controls were drawn from the same catchment areas, participation was almost complete, and women with diseases potentially related to diet and dietary modifications were excluded from the control group.
To ensure that selected p300 peaks contain histone modification marks under study, distal p300 peaks that did not overlap any histone modification peaks were excluded.
Here TFs with less than five probes overlapped between the binding data and the histone modification data were excluded.
Subjects admitted for diseases related to tobacco smoking or alcohol consumption, or any disorder that might have induced long-term modification of diet were excluded from the control group.
Since US and European definitions of UTI showed major differences because of recent modifications, UTI definitions were excluded from the study.
Classification was carried out according to EORTC/MSG criteria with and without modifications (possible IPA cases were excluded), and proven or putative IPA versus no IPA was classified according to the clinical algorithm published by Blot and colleagues [ 35].
